Acquisition Completed

Amneal Pharmaceuticals acquisition of Kashiv BioSciences

US$375m consideration

Announced 22 Apr 2026

Advisers

Kashiv BioSciences

Target

Financial adviser
Legal adviser
Served as an advisor in India
Dhinal Shah Associates

Amneal Pharmaceuticals

Acquirer

Financial adviser
Fairness opinion
Consultants
Boston Consulting Group (as The Boston Consulting Group)
InterPharmaLink AG
Target
Kashiv BioSciences
Acquirer
Amneal Pharmaceuticals
Target based in
United States
Buyer based in
United States
Structure
Private sale
Completed
10 Aug 2026
Sector
Biotech
Tags
Biotech, Pharma, Drug Development

In the league tables

Similar deals

All biotech deals →

Sources

Suggest a correction

A missing adviser, a wrong role or a different outcome. A link to a public source helps.